Psychedelic experience
A psychedelic experience is a temporary altered state of consciousness induced by the consumption of a psychedelic substance. For example, an acid trip is a psychedelic experience brought on by the use of LSD, while a mushroom trip is a psychedelic experience brought on by the use of psilocybin. Psychedelic experiences feature alterations in normal perception such as visual distortions and a subjective loss of self-identity, sometimes interpreted as mystical experiences. Psychedelic experiences lack predictability, as they can range from being highly pleasurable to frightening. The outcome of a psychedelic experience is heavily influenced by the person's mood, personality, expectations, and environment.
Researchers have interpreted psychedelic experiences in light of a range of scientific theories, including model psychosis theory, filtration theory, psychoanalytic theory, entropic brain theory, integrated information theory, and predictive processing. Psychedelic experiences are also induced and interpreted in religious and spiritual contexts.
Along with psilocybin's unique effect on the state of mind, psilocybin has been subject to the idea of being used for therapeutic treatments. This rapidly developing field of psilocybin-assisted therapy has produced promising results in studies targeting mental disorders like depression, post-traumatic stress disorder, and obsessive-compulsive disorder.
Etymology
The term psychedelic was coined by the psychiatrist Humphrey Osmond during written correspondence with author Aldous Huxley and presented to the New York Academy of Sciences by Osmond in 1957. It is derived from the Greek words and thus meaning "mind manifesting," the implication being that psychedelics can develop untapped potentials of the human mind. The term trip was first coined by US Army scientists during the 1950s when they were experimenting with LSD.Phenomenology
Despite several attempts that have been made, starting in the 19th and 20th centuries, to define common phenomenological structures of the effects produced by classic psychedelics, a universally accepted taxonomy does not yet exist.Visual alteration
A prominent element of psychedelic experiences is visual alteration. Psychedelic visual alteration often includes spontaneous formation of complex flowing geometric visual patterning in the visual field. When the eyes are open, the visual alteration is overlaid onto the objects and spaces in the physical environment; when the eyes are closed the visual alteration is seen in the "inner world" behind the eyelids. These visual effects increase in complexity with higher dosages, and also when the eyes are closed. The visual alteration does not normally constitute hallucinations, because the person undergoing the experience can still distinguish between real and imagined visual phenomena, though in some cases, true hallucinations are present. More rarely, psychedelic experiences can include complex hallucinations of objects, animals, people, or even whole landscapes. Visual alterations also include other effects such as afterimages, shifting of color hues, and pareidolia. The appearance of colors and light are usually enhanced.The visuals of psychedelics have been reproduced in video and image form using artificial intelligence.
Mystical experiences
A number of studies by Roland R. Griffiths and other researchers have concluded that high doses of psilocybin and other classic psychedelics trigger mystical experiences in most research participants. Mystical experiences have been measured by a number of psychometric scales, including the Hood Mysticism Scale, the Spiritual Transcendence Scale, and the Mystical Experience Questionnaire. The revised version of the Mystical Experience Questionnaire, for example, asks participants about four dimensions of their experience, namely the "mystical" quality, positive mood such as the experience of amazement, the loss of the usual sense of time and space, and the sense that the experience cannot be adequately conveyed through words. The questions on the "mystical" quality in turn probe multiple aspects: the sense of "pure" being, the sense of unity with one's surroundings, the sense that what one experienced was real, and the sense of sacredness. Some researchers have questioned the interpretation of the results from these studies and whether the framework and terminology of mysticism are appropriate in a scientific context, while other researchers have responded to those criticisms and argued that descriptions of mystical experiences are compatible with a scientific worldview.A group of researchers concluded in a 2011 study that psilocybin "occasions personally and spiritually significant mystical experiences that predict long-term changes in behaviors, attitudes and values".
Some research has found similarities between psychedelic experiences and non-ordinary forms of consciousness experienced in meditation and near-death experiences. The phenomenon of ego dissolution is often described as a key feature of the psychedelic experience.
Individuals who have psychedelic experiences often describe what they experienced as "more real" than ordinary experience. For example, the psychologist Benny Shanon, after observing ayahuasca trips, referred to "the assessment, very common with ayahuasca, that what is seen and thought during the course of intoxication defines the real, whereas the world that is ordinarily perceived is actually an illusion." Similarly, the psychiatrist Stanislav Grof described the LSD experience as "complex revelatory insights into the nature of existence… typically accompanied by a sense of certainty that this knowledge is ultimately more relevant and 'real' than the perceptions and beliefs we share in everyday life."
Bad trips
A "bad trip" is a highly unpleasant psychedelic experience. A bad trip on psilocybin, for instance, often features intense anxiety, confusion, agitation, or even psychotic episodes. Bad trips can be connected to the anxious ego-dissolution dimension of the APZ questionnaire used in research on psychedelic experiences. As of 2011, exact data on the frequency of bad trips are not available. Some research suggests that the risk of a bad trip on psilocybin is higher when multiple drugs are used, when the user has a history of certain mental illnesses, and when the user is not supervised by a sober person.In clinical research settings, precautions including the screening and preparation of participants, the training of the session monitors who will be present during the experience, and the selection of appropriate physical setting can minimize the likelihood of psychological distress. Researchers have suggested that the presence of professional "trip sitters" may significantly reduce the negative experiences associated with a bad trip. In most cases in which anxiety arises during a supervised psychedelic experience, reassurance from the session monitor is adequate to resolve it; however, if distress becomes intense it can be treated pharmacologically, for example with the benzodiazepine diazepam.
Research shows that preparing for the psychedelic experience, as well as the set and setting of the individual and environment they will be in, can help mitigate "bad trips
The psychiatrist Stanislav Grof wrote that unpleasant psychedelic experiences are not necessarily unhealthy or undesirable, arguing that they may have potential for psychological healing and lead to breakthrough and resolution of unresolved psychic issues. Drawing on narrative theory, the authors of a 2021 study of 50 users of psychedelics found that many described bad trips as having been sources of insight or even turning points in life.
Scientific models
Link R. Swanson divides scientific frameworks for understanding psychedelic experiences into two waves. In the first wave, encompassing nineteenth- and twentieth-century frameworks, he includes model psychosis theory, filtration theory, and psychoanalytic theory. In the second wave of theories, encompassing twenty-first-century frameworks, Swanson includes entropic brain theory, integrated information theory, and predictive processing.Model psychosis theory
Researchers studying mescaline in the early twentieth century and LSD in the mid-twentieth century took interest in these drugs as producing a temporary "model psychosis" that could assist researchers and medical students in understanding the experiences of patients with schizophrenia and other psychotic disorders.It was popular to compare between experiences of psychedelics and psychosis in the mid-20th century. The scales used in psychosis and psychedelic research, in the late-20th and 21st century, are more different. Despite the many similarities that were observed between experiences of psychedelics and psychosis in the past, contemporary psychosis and psychedelic research highlight some features more than others, such as mysticism, connectedness, awe, peace, ego dissolution, hallucinations, suspiciousness, disorganization, hostility, grandiosity, and withdrawal.